EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

ECILC.IS

ECILC.ISEIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. TR flag

Istanbul Stock Exchange

44.74

TRY

-0.14

(-0.31%)

2.82EPS

15.87P/E

30.66BMarket Cap

May 09Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

TRAECILC91E0

Return %

Stock

S&P500

-14.54

12.07

257.06

62.30

583.05

98.08

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	1.29	1.64	1.53	1.93	0.78	0.87	1.01	1.28	1.33	1.61	5.06	13.65	12.79	12.11
Basic EPS, GAAP	0.05	0.09	-0.06	0.11	0.27	0.21	0.35	0.24	0.47	1.84	4.35	5.77	1.49	3.01
Free Cash Flow per Basic Share	0.06	-0.06	0.02	0.06	0.22	0.12	0.26	0.24	0.1	0.72	-1.81	3.11	2.36	1.86
Dividend per Share	0.08	0.08	0.08	0.07	0.32	0.5	0.2	0.3	0.07	0.22	0.58	0.98	1.37	0.19
Book Value per Share	1.41	1.36	1.21	1.41	1.4	1.27	1.37	1.27	3.23	4.81	24.02	38.16	39.57	45.7
Tangible Book Value per Share	4.14	4.16	3.94	4.42	4.72	5.06	5.81	6.22	9.34	13.15	43.46	70.48	62.62	71.19
Basic Weighted Avg Shares	685	685	685	608	675	685	685	685	685	685	685	685	685	685
Sales/Revenue/Turnover	887	1,126	1,047	1,171	530	598	692	877	909	1,104	3,466	9,355	8,767	8,298
Operating Margin (%)	0.83	0.85	-1.48	0.39	10.91	9.05	7.73	14.51	12.7	8.34	2.06	3.79	-0.61	-6.99
Depreciation Expense	11	14	19	18	21	10	10	21	23	20	177	738	746	676
Net Income, GAAP	34	61	-43	68	185	146	240	163	322	1,264	2,983	3,956	1,024	2,060
Effective Tax Rate (%)	18.29	33.32	- -	25.35	13.87	16.47	18.68	15.74	16.54	16.04	13.8	11.68	31.46	24.86
Profit Margin (%)	3.88	5.45	-4.14	5.78	34.86	24.43	34.69	18.55	35.43	114.51	86.07	42.28	11.68	24.83
Working Capital	725	723	659	614	561	531	671	643	853	1,254	2,186	2,985	3,364	6,118
LT Debt	- -	- -	31	63	32	15	48	18	50	31	2,464	2,700	1,698	1,845
Total Equity	2,906	2,920	2,761	2,740	3,244	3,481	3,998	4,277	6,410	9,032	31,241	50,312	44,888	50,943
Return on Invested Capital (%)	0.22	0.21	- -	0.11	1.53	1.29	1.15	2.53	1.76	0.97	0.28	0.7	-0.07	-0.88
Return on Capital (%)	3.61	7.03	- -	9.99	18.36	14.5	26.85	18.97	20.5	44.36	26.92	19.97	5.51	9.11
Return on Common Equity (%)	3.5	6.47	-4.92	8.04	20.49	16.09	26.56	18.01	20.89	45.85	30.2	18.57	3.84	7.82

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	41.51%	80.55%	-6.28%
Net Income, GAAP	41.29%	96.96%	-74.12%
Free Cash Flow	42.57%	-21.62%	-24.13%
Total Cash Common Dividend	83.24%	80.56%	40.03%
Total Equity	43.37%	77.38%	-10.78%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Rahmi Faruk Bulent Eczacibasi
Full Time Employees: 1,088
Sector: Healthcare
Industry: Drug Manufacturers - General
Address: BUeyUekdere Caddesi Istanbul Türkiye 34394
IPO Date: May 10, 2000
Website: eczacibasi.com.tr
Similar Companies: Sanofi (SNYNF)
Citius Oncology, Inc. (CTOR)
Amgen Inc. (AMGN)
Johnson & Johnson (JNJ)
Sanofi (SAN.PA)
GSK plc (GSK.L)
Business: EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses primarily in Turkey. The company's Health segment produces and sells human health and veterinary medicines. Its Real Estate Development segment develops real estate properties; and provides consulting services regarding land development and project management. The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.

Year	Q1	Q2	Q3	Q4	FY
2023	2,390	1,891	1,881	2,820	9,355
2024	2,864	1,653	2,082	2,436	8,767
2025	2,127	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	0.18	0.64	0.11	- -	5.77
2024	0.91	-0.5	1.11	- -	1.49
2025	2.25	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	- -	- -	0.08	- -	0.98
2024	- -	- -	0.11	- -	1.37
2025	- -	- -	- -	- -	- -

	Sep'24	Dec'24	Mar'25
Total Current Assets	6,208	7,122	10,543
Accounts Receivable, Net	1,879	2,057	2,374
Cash, Cash Equivalents & STI	2,188	2,687	5,411
Inventories	1,676	1,982	2,167
Total Current Liabilities	3,703	3,758	4,425
Payables & Accruals	- -	- -	- -
ST Debt	1,734	1,502	1,606
Deferred Revenue	- -	- -	- -

	Sep'24	Dec'24	Mar'25
ST Debt	1,734	1,502	1,606
LT Borrowings	1,768	1,655	1,813
LT Finance Leases	53	42	32
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	685	685	685
Market Capitalization	32,783	32,618	30,069

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	1.29	1.64	1.53	1.93	0.78	0.87	1.01	1.28	1.33	1.61	5.06	13.65	12.79	12.11
Basic EPS, GAAP	0.05	0.09	-0.06	0.11	0.27	0.21	0.35	0.24	0.47	1.84	4.35	5.77	1.49	3.01
Free Cash Flow per Basic Share	0.06	-0.06	0.02	0.06	0.22	0.12	0.26	0.24	0.1	0.72	-1.81	3.11	2.36	1.86
Dividend per Share	0.08	0.08	0.08	0.07	0.32	0.5	0.2	0.3	0.07	0.22	0.58	0.98	1.37	0.19
Book Value per Share	1.41	1.36	1.21	1.41	1.4	1.27	1.37	1.27	3.23	4.81	24.02	38.16	39.57	45.7
Tangible Book Value per Share	4.14	4.16	3.94	4.42	4.72	5.06	5.81	6.22	9.34	13.15	43.46	70.48	62.62	71.19
Basic Weighted Avg Shares	685	685	685	608	675	685	685	685	685	685	685	685	685	685
Sales/Revenue/Turnover	887	1,126	1,047	1,171	530	598	692	877	909	1,104	3,466	9,355	8,767	8,298
Operating Margin (%)	0.83	0.85	-1.48	0.39	10.91	9.05	7.73	14.51	12.7	8.34	2.06	3.79	-0.61	-6.99
Depreciation Expense	11	14	19	18	21	10	10	21	23	20	177	738	746	676
Net Income, GAAP	34	61	-43	68	185	146	240	163	322	1,264	2,983	3,956	1,024	2,060
Effective Tax Rate (%)	18.29	33.32	- -	25.35	13.87	16.47	18.68	15.74	16.54	16.04	13.8	11.68	31.46	24.86
Profit Margin (%)	3.88	5.45	-4.14	5.78	34.86	24.43	34.69	18.55	35.43	114.51	86.07	42.28	11.68	24.83
Working Capital	725	723	659	614	561	531	671	643	853	1,254	2,186	2,985	3,364	6,118
LT Debt	- -	- -	31	63	32	15	48	18	50	31	2,464	2,700	1,698	1,845
Total Equity	2,906	2,920	2,761	2,740	3,244	3,481	3,998	4,277	6,410	9,032	31,241	50,312	44,888	50,943
Return on Invested Capital (%)	0.22	0.21	- -	0.11	1.53	1.29	1.15	2.53	1.76	0.97	0.28	0.7	-0.07	-0.88
Return on Capital (%)	3.61	7.03	- -	9.99	18.36	14.5	26.85	18.97	20.5	44.36	26.92	19.97	5.51	9.11
Return on Common Equity (%)	3.5	6.47	-4.92	8.04	20.49	16.09	26.56	18.01	20.89	45.85	30.2	18.57	3.84	7.82

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year

Working Capital

Capital Structure